3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
4
INDUSTRY
2
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Neoplasm Metastasis
1
Interventions
Cisplatin
4
sintilimab
2
pembrolizumab
2
anlotinib
2
Aprepitant
2
nimotuzumab
1
nabiximols
1
camrelizumab
1
apatinib
1
Radiotherapy, Intensity-Modulated
1
Platinum Compounds
1
Palonosetron
1
Paclitaxel
1
Ondansetron
1
Olanzapine
1
Gemcitabine
1
Drug Therapy
1
Dexamethasone
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
UNKNOWN
×
Platinum Compounds
×
Head & Neck
×
Clear all
NCT05136768
2021-11-29
LM-HNSCC
ChineseAMS
Phase 2
Unknown
50 enrolled